- Home
- FOLD vs ABM Comparison
FOLD vs ABM Comparison
Compare FOLD & ABM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- ABM
- Stock Information
- Founded
- FOLD 2002
- ABM 1909
- Country
- FOLD United States
- ABM United States
- Employees
- FOLD N/A
- ABM N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- ABM Diversified Commercial Services
- Sector
- FOLD Health Care
- ABM Finance
- Exchange
- FOLD Nasdaq
- ABM Nasdaq
- Market Cap
- FOLD 2.9B
- ABM 2.9B
- IPO Year
- FOLD 2007
- ABM N/A
- Fundamental
- Price
- FOLD $5.64
- ABM $43.47
- Analyst Decision
- FOLD Buy
- ABM Buy
- Analyst Count
- FOLD 10
- ABM 3
- Target Price
- FOLD $16.22
- ABM $55.00
- AVG Volume (30 Days)
- FOLD 5.3M
- ABM 632.6K
- Earning Date
- FOLD 08-07-2025
- ABM 06-06-2025
- Dividend Yield
- FOLD N/A
- ABM 2.44%
- EPS Growth
- FOLD N/A
- ABM N/A
- EPS
- FOLD N/A
- ABM 1.24
- Revenue
- FOLD $543,141,000.00
- ABM $8,498,200,000.00
- Revenue This Year
- FOLD $19.84
- ABM $2.99
- Revenue Next Year
- FOLD $23.18
- ABM $2.46
- P/E Ratio
- FOLD N/A
- ABM $34.96
- Revenue Growth
- FOLD 28.25
- ABM 3.52
- 52 Week Low
- FOLD $5.62
- ABM $40.85
- 52 Week High
- FOLD $12.65
- ABM $59.78
- Technical
- Relative Strength Index (RSI)
- FOLD 33.65
- ABM 26.31
- Support Level
- FOLD $6.00
- ABM $43.40
- Resistance Level
- FOLD $6.22
- ABM $52.94
- Average True Range (ATR)
- FOLD 0.19
- ABM 1.45
- MACD
- FOLD -0.01
- ABM -0.77
- Stochastic Oscillator
- FOLD 2.70
- ABM 0.73
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About ABM ABM Industries Incorporated
ABM Industries Inc is a provider of integrated facility solutions. It offers its solutions through five segments: Business and Industry, Manufacturing and Distribution, Education, Aviation and Technical solutions. The company derives the majority of its revenue from the business and industry segment, which encompasses janitorial, facilities engineering, and parking services for commercial real estate properties and sports and entertainment venues, hospitals, as well as vehicle maintenance and other services to rental car providers. The company mainly operates in the United States of America.